Published in the JAMA Network Open journal, this new analysis predicts a dramatic rise in the global cancer burden by the middle of the century. Drawing on data from 185 countries and territories, the researchers assess disparities across 36 cancer types.
In 2022, global cancer prevalence stood at 178.9 cases per 100,000 people, with an estimated 20 million new cases and 9.7 million deaths recorded that year. The most common cancers in 2022 were breast, prostate, colorectal, lung, and non-melanoma skin cancers. Lung cancer was the leading cancer, accounting for 12.4 percent of new cases. It was also the leading cause of cancer death, responsible for 18.7 percent of fatalities.
The study projects that lung cancer will remain the top incident cancer in 2050, making up 13.1 percent of new cases, and will continue to be the leading cause of cancer death, accounting for 19.2 percent of deaths. Significantly, the projected 35.3 million cancer cases in 2050 represent a 76.6 percent increase from 2022 levels.
Cancer deaths are forecast to rise even more sharply – by 89.7 percent – to 18.5 million annually. The steepest projected increases in incidence are for non-melanoma skin, bladder, mesothelioma, prostate, pancreatic, and stomach cancers, among others, while the largest projected rises in deaths are for prostate, bladder, non-melanoma skin, and mesothelioma.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
‘Pesticide Cocktails’ Polluting Apples Across Europe, Study Finds
February 20, 2026Over 70 Percent of Tested Baby Foods are Ultra-Processed and Full of Additives
February 20, 2026Global Cancer Deaths Projected to Hit 18.5 Million by 2050
News
Researchers are projecting that, by 2050, there will be 35.3 million people with cancer and 18.5 million cancer deaths annually worldwide.
[Source: thecardiologyadvisor.com]
[Image source: Freepik]
Comment
Published in the JAMA Network Open journal, this new analysis predicts a dramatic rise in the global cancer burden by the middle of the century. Drawing on data from 185 countries and territories, the researchers assess disparities across 36 cancer types.
In 2022, global cancer prevalence stood at 178.9 cases per 100,000 people, with an estimated 20 million new cases and 9.7 million deaths recorded that year. The most common cancers in 2022 were breast, prostate, colorectal, lung, and non-melanoma skin cancers. Lung cancer was the leading cancer, accounting for 12.4 percent of new cases. It was also the leading cause of cancer death, responsible for 18.7 percent of fatalities.
The study projects that lung cancer will remain the top incident cancer in 2050, making up 13.1 percent of new cases, and will continue to be the leading cause of cancer death, accounting for 19.2 percent of deaths. Significantly, the projected 35.3 million cancer cases in 2050 represent a 76.6 percent increase from 2022 levels.
Cancer deaths are forecast to rise even more sharply – by 89.7 percent – to 18.5 million annually. The steepest projected increases in incidence are for non-melanoma skin, bladder, mesothelioma, prostate, pancreatic, and stomach cancers, among others, while the largest projected rises in deaths are for prostate, bladder, non-melanoma skin, and mesothelioma.
To check out Dr. Rath’s Cellular Health recommendations for cancer, see this page on our website.
Dr. Rath Health Foundation
Related posts
Swiss Anti-GMO Initiative Handed in at Bern
Read more